Beleodaq is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Acrotech Biopharma Llc. The primary component is Belinostat.
| Product ID | 72893-002_0d662a88-5ace-48ff-9545-f3abff28d2a9 |
| NDC | 72893-002 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Beleodaq |
| Generic Name | Belinostat |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-07-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA206256 |
| Labeler Name | Acrotech Biopharma LLC |
| Substance Name | BELINOSTAT |
| Active Ingredient Strength | 500 mg/10mL |
| Pharm Classes | Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2014-07-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA206256 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-07-21 |
| Ingredient | Strength |
|---|---|
| BELINOSTAT | 500 mg/10mL |
| SPL SET ID: | 2e8ef36b-71fa-4492-a16f-577d5f7d111d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68152-108 | Beleodaq | Belinostat |
| 69605-002 | Beleodaq | Belinostat |
| 72893-002 | Beleodaq | Belinostat |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BELEODAQ 86140026 4626277 Live/Registered |
ACROTECH BIOPHARMA LLC 2013-12-10 |